Serum peptides as candidate biomarkers for relapsing polychondritis

• Published in: Journal of mass spectrometry and advances in the clinical lab Vol. 37; pp. 28 - 38
• Main Authors: Sato, Toshiyuki, Sato, Masaaki, Nagai, Kouhei, Fukasawa, Masahiko, Nagashima, Yoshiaki, Uchida, Teisuke, Tsutiya, Atsuhiro, Omoteyama, Kazuki, Arito, Mitsumi, Takakuwa, Yukiko, Ooka, Seido, Suematsu, Naoya, Kawahata, Kimito, Yamano, Yoshihisa, Kato, Tomohiro, Kurokawa, Manae S.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.08.2025; Elsevier
• Subjects: Biological markers; Mass spectrometry; Relapsing polychondritis; Serum peptides; FIBA; Relapsing polychondritis; OPLS-DA; AUROC; MALDI-TOF/TOF-MS; PCA; RA; Serum peptides; ANCA; FPA; GPA; HC; Biological markers; VIP; Mass spectrometry; RP; αCDC; ELISA
• ISSN: 2667-145X; 2667-145X
• DOI: 10.1016/j.jmsacl.2025.04.001

•Identified serum peptides useful for diagnosis of relapsing polychondritis (RP)•The peptides are fragments of fibrinogen α.•A candidate diagnostic peptide biomarker was 83.3% sensitive and 71.7% specific. Relapsing polychondritis (RP) is an intractable disease characterized by recurrent inflammation of cartilaginous tissue throughout the body. It is difficult to accurately diagnose RP, and no useful biomarkers have yet been identified. We analyzed serum peptide profiles to identify novel candidate biomarkers for RP. Thirty-seven patients with RP, 42 patients with rheumatoid arthritis (RA), and 35 healthy control (HC) subjects were divided into training and testing sets. Seven patients demonstrating granulomatosis with polyangiitis (GPA) were used for validation. The ion intensity of serum peptides was comprehensively measured by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry and applied to a supervised multivariate analysis. Peptides of interest were analyzed by liquid chromatography-tandem mass spectrometry. In the training set, models developed based on 11 (RP/HC-11P model), 9 (RP/RA-9P model), and 14 (RP/nonRP-14P model) peptides, out of 160 peptides detected were able to completely discriminate the RP group from the HC, RA, and nonRP (HC + RA) groups. Almost all of the 15 identified discriminatory peptides comprising these models were fragments of proteins associated with coagulation. Four models, each consisting of 4 out of 10 identified peptides of the RP/nonRP-14P model (models RP/nonRP-4P-2, -10, -11, and -38), provided ≥ 70.0 % sensitivity and specificity when applied to the validation set (the testing set and the GPA group) (AUROC, 0.779–0.815). Notably, the RP/nonRP-4P-2 model provided 83.3 % sensitivity and 71.7 % specificity in the validation set (AUROC, 0.802). Serum peptides are useful as candidate biomarkers for discriminating RP and may be involved in the pathophysiology of RP.